首页> 美国卫生研究院文献>Aging (Albany NY) >Adaptive sequence convergence of the tumor suppressor ADAMTS9 between small-bodied mammals displaying exceptional longevity
【2h】

Adaptive sequence convergence of the tumor suppressor ADAMTS9 between small-bodied mammals displaying exceptional longevity

机译:小体哺乳动物之间肿瘤抑制因子ADAMTS9的适应性序列收敛显示出超长的寿命

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Maximum lifespan varies by two orders of magnitude across mammals. How such divergent lifespans have evolved remains an open question, with ramifications that may potentially lead to therapies for age-related diseases in humans. Several species of microbats as well as the naked mole-rat live much longer than expected given their small sizes, show reduced susceptibility to neoplasia, and largely remain healthy and reproductively capable throughout the majority of their extended lifespans. The convergent evolution of extreme longevity in these two groups allows for the opportunity to identify potentially important aging related genes that have undergone adaptive sequence convergence in these long-lived, yet small-bodied species. Here, we have tested 4,628 genes for evidence of convergence between the microbats and naked mole-rat. We find a strong signal of adaptive sequence convergence in the gene A disintegrin-like and metalloprotease with thrombospondin type 1 motifs 9 (ADAMTS9). We also provide evidence that the shared substitutions were driven by selection. Intriguingly, ADAMTS9 is a known inhibitor of the mTor pathway and has been implicated in several aging related processes.
机译:哺乳动物的最大寿命变化两个数量级。这种不同的寿命如何演变仍是一个悬而未决的问题,其后果可能导致人类与年龄有关的疾病的治疗。鉴于它们的体积小,几种微型蝙蝠和裸露的mole鼠的寿命比预期的要长得多,它们对瘤形成的敏感性降低,并且在其大部分寿命中都保持健康和生殖能力。这两组中超长寿的融合进化为寻找潜在重要的衰老相关基因提供了机会,这些基因已经在这些长寿但小体的物种中经历了适应性序列收敛。在这里,我们已经测试了4,628个基因,以证明微型蝙蝠与裸mole鼠之间的融合。我们发现在A基因整合素样和金属蛋白酶与血小板反应蛋白1型基序9(ADAMTS9)的自适应序列收敛的强信号。我们还提供证据表明共享替代是由选择驱动的。有趣的是,ADAMTS9是mTor途径的已知抑制剂,并且与多种衰老相关过程有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号